Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Feb 10;7(1):87-97.
doi: 10.5306/wjco.v7.i1.87.

Overview, prevention and management of chemotherapy extravasation

Affiliations
Review

Overview, prevention and management of chemotherapy extravasation

Firas Y Kreidieh et al. World J Clin Oncol. .

Abstract

Chemotherapy extravasation remains an accidental complication of chemotherapy administration and may result in serious damage to patients. We review in this article the clinical aspects of chemotherapy extravasation and latest advances in definitions, classification, prevention, management and guidelines. We review the grading of extravasation and tissue damage according to various chemotherapeutic drugs and present an update on treatment and new antidotes including dexrazoxane for anthracyclines extravasation. We highlight the importance of education and training of the oncology team for prevention and prompt pharmacological and non-pharmacological management and stress the availability of new antidotes like dexrazoxane wherever anthracyclines are being infused.

Keywords: Antidote; Chemotherapy; Dexrazoxane; Dimethyl sulfoxide; Extravasation; Hyaluronidase; Tissue damage; Vesicant.

PubMed Disclaimer

References

    1. Coyle CE, Griffie J, Czaplewski LM. Eliminating extravasation events: a multidisciplinary approach. J Infus Nurs. 2014;37:157–164. - PubMed
    1. Hadaway L. Infiltration and extravasation. Am J Nurs. 2007;107:64–72. - PubMed
    1. Cassagnol M, McBride A. Management of Chemotherapy Extravasations. US Pharm, 2009: 3-11
    1. El-Saghir N, Otrock Z, Mufarrij A, Abou-Mourad Y, Salem Z, Shamseddine A, Abbas J. Dexrazoxane for anthracycline extravasation and GM-CSF for skin ulceration and wound healing. Lancet Oncol. 2004;5:320–321. - PubMed
    1. Chang PH, Wang MT, Chen YH, Chen YY, Wang CH. Docetaxel extravasation results in significantly delayed and relapsed skin injury: A case report. Oncol Lett. 2014;7:1497–1498. - PMC - PubMed